Scott+Scott Attorneys at Law LLP Files Securities Class Action Against TransMedics Group, Inc. (NASDAQ: TMDX)
TransMedics Group, Inc. (TMDX)
Last transmedics group, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the District of Massachusetts against TransMedics Group, Inc. (“TransMedics Group” or the “Company”) (NASDAQ: TMDX), and certain of its former and current officers and/or directors (collectively, “Defendants”). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b-5) on behalf of all persons other than Defendants who purchased or otherwise acquired publicly traded TransMedics securities between February 28, 2023, and January 10, 2025, inclusive (the “Class Period”), and were damaged thereby (the “Class”). The Class Action filed by Scott+Scott is captioned: Collins v. TransMe
Show less
Read more
Impact Snapshot
Event Time:
TMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMDX alerts
High impacting TransMedics Group, Inc. news events
Weekly update
A roundup of the hottest topics
TMDX
News
- TransMedics Group (NASDAQ:TMDX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $147.00 to $148.00. They now have a "buy" rating on the stock.MarketBeat
- TransMedics Group (NASDAQ:TMDX) had its price target raised by analysts at Needham & Company LLC from $148.00 to $166.00. They now have a "buy" rating on the stock.MarketBeat
- TransMedics Group (NASDAQ:TMDX) had its price target raised by analysts at Morgan Stanley from $123.00 to $135.00. They now have an "equal weight" rating on the stock.MarketBeat
- TransMedics to Participate in the Piper Sandler 37th Annual Healthcare ConferencePR Newswire
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire
TMDX
Earnings
- 10/29/25 - Beat
TMDX
Sec Filings
- 12/5/25 - Form 4
- 12/5/25 - Form 4
- 12/3/25 - Form 144
- TMDX's page on the SEC website